Obagi Tretinoin 0.05% Gel Obagi

A prescription retinoid indicated for the topical treatment of acne vulgaris.

Obagi Tretinoin 0.05% is a retinoid indicated for the topical treatment of acne vulgaris.

Tretinoin is the generic name for synthetic, first-generation all-trans-retinoic acid. Topical tretinoin first arrived on the dermatology scene in the 1960s. It is a prescription drug approved to treat acne, and in a few other FDA-approved products (which does not apply to our tretinoin products) as an adjunctive agent to help lessen fine facial wrinkling for patients who use comprehensive skincare and sun avoidance programs.

Benefits:

Available in multiple strengths and formulations by prescription only.

Obagi tretinoin creams and gel work deep inside the skin to treat acne.

All Obagi tretinoin formulations are fragrance free.

Contact your healthcare provider to purchase, or find a nearby physician who offers this product.

HOW TO USE
Morning Routine:

Apply a moisturizer, preferably with sunscreen, that will not aggravate your acne.

Nighttime Routine:

Wash with a mild soap and dry skin gently. Wait 20 to 30 minutes to allow skin to completely dry. Squeeze no more than half an inch of medication onto fingertip; more medication will not yield faster or better results and may cause irritation.

Apply onto face, covering affected area lightly, starting with your forehead, chin, and both cheeks, then spread over the entire affected area.

Avoid corners of the nose, mouth, eyes, and open wounds

IMPORTANT SAFETY INFORMATION:

For Topical Use Only

Contraindications: Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

Precautions: Exposure to sunlight, including sunlamps, should be minimized during the use of Tretinoin Cream and Gel, and patients with sunburn should be advised not to use the product until fully recovered.

Patients who have considerable sun exposure due to occupation and those with inherent sensitivity to the sun should exercise particular caution. Use of sunscreen products and protective clothing over treated areas is recommended when exposure cannot be avoided.

Weather extremes, such as wind or cold, also may be irritating to patients using tretinoin.

Tretinoin Gel should be kept away from the eyes, the mouth, angles of the nose, and mucous membranes. Topical use may induce severe local erythema and peeling at the site of application. If the degree of local irritation warrants, patients should be directed to use the medication less frequently, discontinue use temporarily, or discontinue use altogether.

Tretinoin has been reported to cause severe irritation on eczematous skin and should be used with utmost caution in patients with this condition.

Pregnancy Tretinoin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Adverse Reactions The skin of certain sensitive individuals may become excessively red, edematous, blistered, or crusted. If these effects occur, treatment should be discontinued or adjusted to a level the patient can tolerate.

To report SUSPECTED ADVERSE REACTIONS contact FDA at fda.gov/medwatch or call 1-800-FDA-1088.

INGREDIENTS
Key Ingredients:

Active Ingredient: 0.05% Tretinoin

Derived from Vitamin A in the form of retinoic acid, the active ingredient tretinoin is a retinoid, widely recognized in skin care as a powerful and effective acne treatment.

Contains micronized tretinoin in an aqueous gel composed of purified water, glycerin, and soluble collagen. Soluble collagen comprises methylparaben, propylparaben, ethylparaben, butylparaben, isobutylparaben, phenoxyethanol, fish collagen, and water.

Each gram contains: Tretinoin Gel is a translucent to opaque, pale yellow gel containing 0.05% tretinoin, by weight. Other components of this formulation are benzyl alcohol, butylparaben, butylated hydroxytoluene, carbomer homopolymer Type C, ethylparaben, fish collagen hydrolyzates, glycerin, isobutylparaben, methylparaben, octoxynol 9, phenoxyethanol, propylparaben, purified water, sodium hyaluronate, and trolamine.